Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: The nucleoside inflammation, coagulation and endothelial function (NICE) study
David A. Wohl*, Gretchen Arnoczy, Carl J. Fichtenbaum, Thomas Campbell, Babafemi Taiwo, Charles Hicks, Grace A. McComsey, Susan Koletar, Paul Sax, Pablo Tebas, Belinda Ha, Kelly Massengale, Kendall Walsh, James H. Stein
Dive into the research topics of 'Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: The nucleoside inflammation, coagulation and endothelial function (NICE) study'. Together they form a unique fingerprint.